Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Ruthenium Catalyzed C H Silylation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN115215895A details a cost-effective ruthenium-catalyzed synthesis of five-membered silicon-containing fused heterocycles, offering significant supply chain advantages for pharmaceutical intermediates.
Patent CN109608488A reveals Ru-catalyzed route for quinoline derivatives. Offers cost reduction and scalable supply chain solutions for global pharmaceutical intermediates.
Novel ruthenium-catalyzed synthesis of 2-alkyl silicon-benzamide compounds. Reduces steps, eliminates halogenated by-products, ensures high-purity pharmaceutical intermediate supply.
Patent CN109651421A details a ruthenium-catalyzed one-pot synthesis for high-purity pharmaceutical intermediates, offering significant cost and supply chain advantages.
Patent CN109651421B details a cost-effective Ru-catalyzed C-H silylation. Offers high yields up to 85% for pharmaceutical intermediates, ensuring reliable supply chain stability.